Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Pozycja w akcjach #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Cena akcji
$25.61
Ostatnia synchronizacja: 2025-10-10
Kapitalizacja rynkowa
$1.37B
Zmiana (1 dzień)
0.20%
Zmiana (1 rok)
1.55%
Kraj
US
Handel Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategoria

Wskaźnik P/S dla Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Wskaźnik P/S na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji Harrow Health, Inc. 8.625% Senior Notes due 2026, obecny wskaźnik P/S (TTM) wynosi 0. Na koniec 2026 wynosił 0.
Historia wskaźnika P/S dla Harrow Health, Inc. 8.625% Senior Notes due 2026 od 2026 do 2026
Wskaźnik P/S na koniec każdego roku
Rok Wskaźnik P/S Zmień
Za mało danych dla podanych dat.
Wskaźnik P/S dla podobnych firm lub konkurentów